In a new study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated that the spinal cord is far more than just a transmission pathway that ...

Paleontologist Caleb Brown said that the fossil is "exceptionally uncommon"—not least because the pterosaur was a juvenile.

In a ground-breaking study, scientists at the Leibniz Institute for Neurobiology (LIN) and University Hospital Magdeburg demonstrated that the spinal cord is far more than just a transmission pathway ...

COLEMAN, Texas — Injured Army Sergeant Willard "Will" Hoyum has been given a mortgage-free smart home from the Tunnels to Towers Foundation. SGT Hoyum, a Coleman resident, enlisted in the United ...

A scan of the bone found that the edges of the puncture don’t match the break points on the rest of the bone, meaning it wasn’t caused during the fossilization process, and cemented and compacted ...

Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a severe form of metastatic brain cancer that spreads to membranes surrounding ...

Brazilian charger and world record holder for the largest wave ever surfed by a woman Maya Gaberia took to Instagram on Tuesday to announce her retirement from professional big-wave surfing. "It’s ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion centers.

Spinraza generated worldwide sales of $1.15 billion for the first nine months of 2024. Biogen licensed the global rights to develop, manufacture and commercialize Spinraza from Ionis Pharmaceuticals, ...

The fossilized neck bone of a flying reptile unearthed in Canada shows tell-tale signs of being bitten by a crocodile-like ...

Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SMA) drug Spinraza are now under review in the US and Europe.